TPI Cancer Research Results
TPI, Triosephosphate Isomerase: Click to Expand ⟱
| Source: |
| Type: |
TPI (Triosephosphate Isomerase)
– TPI is a key glycolytic enzyme that catalyzes the reversible interconversion of dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (G3P).
– By facilitating glycolysis, TPI plays a crucial role in energy production and metabolic flux in cells.
– Enhanced Glycolytic Activity: Elevated TPI levels can correlate with increased glycolytic flux, supporting the energetic and biosynthetic demands of rapidly proliferating tumor cells.
– Clinical Outcomes: Several studies have suggested that overexpression of TPI may be associated with more aggressive tumor behavior and poorer patient prognosis, though the specific prognostic value can be context- and cancer type–dependent.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Melanoma, |
SK-MEL-28 |
|
|
|
- |
in-vitro, |
Melanoma, |
A375 |
|
|
|
LDHA↓, both baicalein and baicalin inhibited LDHα expression in Mel586, A375, and B16F0 melanoma cells, and ENO1 expression in SK-MEL-2 and A375 cells, as well as partially suppressed PKM2 expression in SK-MEL-2, A375, and B16F0 tumor cells
ENO1↓,
PKM2↓,
GLUT1↓, Baicalein and baicalin treatments markedly suppressed gene expression of Glut1, Glut3, HK2, TPI, GPI, and PFK1 in both human and mouse melanoma cells
GLUT3↓,
HK2↓,
PFK1↓,
GPI↓,
TPI↓,
GlucoseCon↓, baicalein and baicalin significantly inhibited glucose uptake abilities of four melanoma cell lines no matter of N-RAS and B-RAF mutation statuses
TumCG↓, baicalein and baicalin strongly suppressed tumor growth and proliferation of both human and mouse melanoma cells
TumCP↓,
mTORC1↓, Down-Regulation of mTORC1-HIF1α Signaling in Melanoma Cells Is Responsible for Glucose Metabolism Inhibition Induced by Baicalein and Baicalin
Hif1a↓,
Ki-67↓, We observed that baicalein and baicalin treatments markedly suppressed tumor cell proliferation as indicated by a decrease of Ki-67+ cell populations in tumor tissues
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
ENO1↓, 1, GlucoseCon↓, 1, GPI↓, 1, HK2↓, 1, LDHA↓, 1, PFK1↓, 1, PKM2↓, 1, TPI↓, 1,
Proliferation, Differentiation & Cell State ⓘ
mTORC1↓, 1, TumCG↓, 1,
Migration ⓘ
Ki-67↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, GLUT3↓, 1,
Clinical Biomarkers ⓘ
Ki-67↓, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TPI, Triosephosphate Isomerase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1285 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page